Literature DB >> 24591636

Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance.

Buvana Ravishankar1, Rahul Shinde, Haiyun Liu, Kapil Chaudhary, Jillian Bradley, Henrique P Lemos, Phillip Chandler, Masato Tanaka, David H Munn, Andrew L Mellor, Tracy L McGaha.   

Abstract

Tolerance to apoptotic cells is essential to prevent inflammatory pathology. Though innate responses are critical for immune suppression, our understanding of early innate immunity driven by apoptosis is lacking. Herein we report apoptotic cells induce expression of the chemokine CCL22 in splenic metallophillic macrophages, which is critical for tolerance. Systemic challenge with apoptotic cells induced rapid production of CCL22 in CD169(+) (metallophillic) macrophages, resulting in accumulation and activation of FoxP3(+) Tregs and CD11c(+) dendritic cells, an effect that could be inhibited by antagonizing CCL22-driven chemotaxis. This mechanism was essential for suppression after apoptotic cell challenge, because neutralizing CCL22 or its receptor, reducing Treg numbers, or blocking effector mechanisms abrogated splenic TGF-β and IL-10 induction; this promoted a shift to proinflammatory cytokines associated with a failure to suppress T cells. Similarly, CCR4 inhibition blocked long-term, apoptotic cell-induced tolerance to allografts. Finally, CCR4 inhibition resulted in a systemic breakdown of tolerance to self after apoptotic cell injection with rapid increases in anti-dsDNA IgG and immune complex deposition. Thus, the data demonstrate CCL22-dependent chemotaxis is a key early innate response required for apoptotic cell-induced suppression, implicating a previously unknown mechanism of macrophage-dependent coordination of early events leading to stable tolerance.

Entities:  

Keywords:  autoimmunity; migration; regulation; spleen; transplantation

Mesh:

Substances:

Year:  2014        PMID: 24591636      PMCID: PMC3964059          DOI: 10.1073/pnas.1320924111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

2.  Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL.

Authors:  Thomas S Griffith; Hirotaka Kazama; Rebecca L VanOosten; James K Earle; John M Herndon; Douglas R Green; Thomas A Ferguson
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  Restoration of tolerance in lupus by targeted inhibitory receptor expression.

Authors:  Tracy L McGaha; Brian Sorrentino; Jeffrey V Ravetch
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

4.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

5.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Authors:  Jagadeesh Bayry; Elma Z Tchilian; Matthew N Davies; Emily K Forbes; Simon J Draper; Srini V Kaveri; Adrian V S Hill; Michel D Kazatchkine; Peter C L Beverley; Darren R Flower; David F Tough
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

7.  Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.

Authors:  Kazuhiro Yokoyama; Noriko Ishikawa; Susumu Igarashi; Noriyuki Kawano; Naoyuki Masuda; Wataru Hamaguchi; Shingo Yamasaki; Yohei Koganemaru; Kazuyuki Hattori; Takahiro Miyazaki; Shin-Ichi Ogino; Yuzo Matsumoto; Makoto Takeuchi; Mitsuaki Ohta
Journal:  Bioorg Med Chem       Date:  2008-11-17       Impact factor: 3.641

8.  Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens.

Authors:  Yasunobu Miyake; Kenichi Asano; Hitomi Kaise; Miho Uemura; Manabu Nakayama; Masato Tanaka
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

9.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.

Authors:  Elin Jaensson; Heli Uronen-Hansson; Oliver Pabst; Bertus Eksteen; Jiong Tian; Janine L Coombes; Pia-Lena Berg; Thomas Davidsson; Fiona Powrie; Bengt Johansson-Lindbom; William W Agace
Journal:  J Exp Med       Date:  2008-08-18       Impact factor: 14.307

View more
  49 in total

Review 1.  Extracellular traps and macrophages: new roles for the versatile phagocyte.

Authors:  Devin M Boe; Brenda J Curtis; Michael M Chen; Jill A Ippolito; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2015-04-15       Impact factor: 4.962

2.  T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice.

Authors:  Wei Li; Ahmed S Elshikha; Caleb Cornaby; Xiangyu Teng; Georges Abboud; Josephine Brown; Xueyang Zou; Leilani Zeumer-Spataro; Brian Robusto; Seung-Chul Choi; Kristianna Fredenburg; Amy Major; Laurence Morel
Journal:  JCI Insight       Date:  2020-06-04

3.  Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

Authors:  Arnaud Machelart; Abir Khadrawi; Aurore Demars; Kevin Willemart; Carl De Trez; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 4.  Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA.

Authors:  Henrique Lemos; Lei Huang; Tracy L McGaha; Andrew L Mellor
Journal:  Eur J Immunol       Date:  2014-08-25       Impact factor: 5.532

Review 5.  Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.

Authors:  Theodore S Johnson; Tracy Mcgaha; David H Munn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.

Authors:  David H Munn; Madhav D Sharma; Theodore S Johnson; Paulo Rodriguez
Journal:  Cancer Immunol Immunother       Date:  2017-05-09       Impact factor: 6.968

Review 7.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

Review 8.  STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?

Authors:  Henrique Lemos; Lei Huang; Tracy McGaha; Andrew L Mellor
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

9.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

10.  B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens.

Authors:  Rahul Shinde; Michiko Shimoda; Kapil Chaudhary; Haiyun Liu; Eslam Mohamed; Jillian Bradley; Sridhar Kandala; Xia Li; Kebin Liu; Tracy L McGaha
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.